about
Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair.Novel lansoprazole-loaded nanoparticles for the treatment of gastric acid secretion-related ulcers: in vitro and in vivo pharmacokinetic pharmacodynamic evaluation.Dextran sodium sulfate (DSS) induces colitis in mice by forming nano-lipocomplexes with medium-chain-length fatty acids in the colonA(₂B)AR expression in non-immune cells plays an important role in the development of murine colitisTargeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles.Plant derived edible nanoparticles as a new therapeutic approach against diseases.Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders.Nanotechnology in the treatment of inflammatory bowel diseases.Nanocarriers: a versatile approach for mucosal vaccine delivery.Potential prospects of nanomedicine for targeted therapeutics in inflammatory bowel diseases.Synthesis of pH stable, blue light-emitting diode-excited, fluorescent silica nanoparticles and effects on cell behavior.Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.Nanotherapeutics for the treatment of inflammatory bowel disease.Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis
P2860
Q24318444-231AAA80-968C-4569-8AAC-EABF0D14FFFDQ33574120-E27021B0-8B18-48E8-B21E-049A009D708BQ34199709-71BCBC52-40D4-412B-8190-70A2A5D77670Q36218394-E30412C4-7BDB-4AC5-A5F3-2B411A1A85D0Q36498783-95ACF87F-E94A-4BE3-AD1A-A68BBBDC0929Q37012929-BC0DBF3C-A9B6-4ED7-AE4A-AD0F5B68CB5BQ38105404-FAF3F530-30DE-4A5C-8C9B-044B4285893EQ38200842-47BB12B9-E9C5-4129-9C3E-A015C8687E9BQ38358876-CD6A3AEE-C1C0-427C-99EA-00B8057FBB01Q43202907-27E06F5C-FC72-4B7D-9E06-EE36AED65D79Q47113686-1AC6894B-C8D9-4FC4-BB30-7EA354AF4243Q47677851-AC0BBF58-8123-4C4E-9B35-5CC7FF7AF25FQ47941914-4405F762-8258-49D4-92A6-275020C15261Q47980720-4AF2031F-7DD7-4417-8E7C-4755D15636C5Q57490343-CFC9AD3A-9E75-4184-85A8-3A0C254149C6
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Nanomedicine in GI
@ast
Nanomedicine in GI
@en
Nanomedicine in GI
@nl
type
label
Nanomedicine in GI
@ast
Nanomedicine in GI
@en
Nanomedicine in GI
@nl
prefLabel
Nanomedicine in GI
@ast
Nanomedicine in GI
@en
Nanomedicine in GI
@nl
P2093
P2860
P356
P1476
Nanomedicine in GI
@en
P2093
David S Wilson
Didier Merlin
Guillaume Dalmasso
Hamed Laroui
Khalid Salaita
Niren Murthy
Shanthi V Sitaraman
P2860
P304
P356
10.1152/AJPGI.00466.2010
P577
2010-12-09T00:00:00Z